These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31905764)

  • 1. The Inhibitory Effects of Slow-Releasing Hydrogen Sulfide Donors in the Mechanical Allodynia, Grip Strength Deficits, and Depressive-Like Behaviors Associated with Chronic Osteoarthritis Pain.
    Batallé G; Cabarga L; Pol O
    Antioxidants (Basel); 2019 Dec; 9(1):. PubMed ID: 31905764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with slow-releasing hydrogen sulfide donors inhibits the nociceptive and depressive-like behaviours accompanying chronic neuropathic pain: Endogenous antioxidant system activation.
    Cabarga L; Batallé G; Pol O
    J Psychopharmacol; 2020 Jul; 34(7):737-749. PubMed ID: 32312156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Recovery of Cognitive and Affective Deficiencies Linked with Chronic Osteoarthritis Pain and Implicated Pathways by Slow-Releasing Hydrogen Sulfide Treatment.
    Batallé G; Bai X; Pouso-Vázquez E; Roch G; Rodríguez L; Pol O
    Antioxidants (Basel); 2021 Oct; 10(10):. PubMed ID: 34679766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Interaction between Carbon Monoxide and Hydrogen Sulfide during Chronic Joint Pain in Young Female Mice.
    Batallé G; Bai X; Pol O
    Antioxidants (Basel); 2022 Jun; 11(7):. PubMed ID: 35883761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogen Sulfide Inhibits Inflammatory Pain and Enhances the Analgesic Properties of Delta Opioid Receptors.
    Porta A; Rodríguez L; Bai X; Batallé G; Roch G; Pouso-Vázquez E; Balboni G; Pol O
    Antioxidants (Basel); 2021 Dec; 10(12):. PubMed ID: 34943080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Beneficial Effects of Heme Oxygenase 1 and Hydrogen Sulfide Activation in the Management of Neuropathic Pain, Anxiety- and Depressive-like Effects of Paclitaxel in Mice.
    Roch G; Batallé G; Bai X; Pouso-Vázquez E; Rodríguez L; Pol O
    Antioxidants (Basel); 2022 Jan; 11(1):. PubMed ID: 35052626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the Sigma-1 Receptor Relieves Cognitive and Emotional Impairments Associated to Chronic Osteoarthritis Pain.
    Carcolé M; Zamanillo D; Merlos M; Fernández-Pastor B; Cabañero D; Maldonado R
    Front Pharmacol; 2019; 10():468. PubMed ID: 31130863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Anxiolytic and Antidepressant Effects of Diallyl Disulfide and GYY4137 in Animals with Chronic Neuropathic Pain.
    Bai X; Batallé G; Pol O
    Antioxidants (Basel); 2021 Jul; 10(7):. PubMed ID: 34356307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the dynorphin/KOR system on the nociceptive, emotional and cognitive manifestations of joint pain in mice.
    Negrete R; García Gutiérrez MS; Manzanares J; Maldonado R
    Neuropharmacology; 2017 Apr; 116():315-327. PubMed ID: 27567942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulforaphane Inhibited the Nociceptive Responses, Anxiety- and Depressive-Like Behaviors Associated With Neuropathic Pain and Improved the Anti-allodynic Effects of Morphine in Mice.
    Ferreira-Chamorro P; Redondo A; Riego G; Leánez S; Pol O
    Front Pharmacol; 2018; 9():1332. PubMed ID: 30542282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment With the Delta Opioid Agonist UFP-512 Alleviates Chronic Inflammatory and Neuropathic Pain: Mechanisms Implicated.
    Polo S; Díaz AF; Gallardo N; Leánez S; Balboni G; Pol O
    Front Pharmacol; 2019; 10():283. PubMed ID: 30971925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Treatment for the Cognitive and Emotional Deficits Linked with Paclitaxel-Induced Peripheral Neuropathy in Mice.
    Martínez-Martel I; Bai X; Batallé G; Pol O
    Antioxidants (Basel); 2022 Dec; 11(12):. PubMed ID: 36552595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation by Sigma-1 Receptor of Morphine Analgesia and Tolerance: Nociceptive Pain, Tactile Allodynia and Grip Strength Deficits During Joint Inflammation.
    Montilla-García Á; Tejada MÁ; Ruiz-Cantero MC; Bravo-Caparrós I; Yeste S; Zamanillo D; Cobos EJ
    Front Pharmacol; 2019; 10():136. PubMed ID: 30853912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grip strength in mice with joint inflammation: A rheumatology function test sensitive to pain and analgesia.
    Montilla-García Á; Tejada MÁ; Perazzoli G; Entrena JM; Portillo-Salido E; Fernández-Segura E; Cañizares FJ; Cobos EJ
    Neuropharmacology; 2017 Oct; 125():231-242. PubMed ID: 28760650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglial pannexin-1 channel activation is a spinal determinant of joint pain.
    Mousseau M; Burma NE; Lee KY; Leduc-Pessah H; Kwok CHT; Reid AR; O'Brien M; Sagalajev B; Stratton JA; Patrick N; Stemkowski PL; Biernaskie J; Zamponi GW; Salo P; McDougall JJ; Prescott SA; Matyas JR; Trang T
    Sci Adv; 2018 Aug; 4(8):eaas9846. PubMed ID: 30101191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine Attenuates Osteoarthritis Pain and Matrix Metalloproteinase-9 Expression via the α7 Nicotinic Acetylcholine Receptor.
    Teng P; Liu Y; Dai Y; Zhang H; Liu WT; Hu J
    J Immunol; 2019 Jul; 203(2):485-492. PubMed ID: 31152077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel slow-releasing hydrogen sulfide donor, FW1256, exerts anti-inflammatory effects in mouse macrophages and in vivo.
    Huang CW; Feng W; Peh MT; Peh K; Dymock BW; Moore PK
    Pharmacol Res; 2016 Nov; 113(Pt A):533-546. PubMed ID: 27687956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Compound ITC-3 Activates the Nrf2 Signaling and Provides Neuroprotection in Parkinson's Disease Models.
    Lee JA; Son HJ; Park KD; Han SH; Shin N; Kim JH; Kim HR; Kim DJ; Hwang O
    Neurotox Res; 2015 Nov; 28(4):332-45. PubMed ID: 26233727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of isothiocyanate-based compounds on different forms of persistent pain.
    Lucarini E; Micheli L; Martelli A; Testai L; Calderone V; Ghelardini C; Di Cesare Mannelli L
    J Pain Res; 2018; 11():2905-2913. PubMed ID: 30510445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel synthetic isothiocyanate ITC-57 displays antioxidant, anti-inflammatory, and neuroprotective properties in a mouse Parkinson's disease model.
    Lee JA; Son HJ; Kim JH; Park KD; Shin N; Kim HR; Kim EM; Kim DJ; Hwang O
    Free Radic Res; 2016; 50(11):1188-1199. PubMed ID: 27598306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.